CDTX
Cidara Therapeutics, Inc. - Common Stock (CDTX)
$80
About Cidara Therapeutics, Inc. - Common Stock (CDTX)
Cidara Therapeutics, Inc. is a biotechnology company, which engages in the discovery, development, and commercialization of therapeutics for patients facing serious diseases, specifically oncology and infectious diseases. Its product pipeline includes Rezafungin Acetate and Cloudbreak. The company was founded by Kevin M. Forrest, Kevin J. Judice, and H. Shaw Warren in December 2012 and is headquartered in San Diego, CA.
Details
Daily high
$50.88
Daily low
$49.77
Price at open
$50.88
52 Week High
$56.83
52 Week Low
$10.14
Market cap
1.1B
Dividend yield
0.00%
Volume
23,148
Avg. volume
1.5M
P/E ratio
-1.75
Cidara Therapeutics, Inc. - Common Stock News
Details
Daily high
$50.88
Daily low
$49.77
Price at open
$50.88
52 Week High
$56.83
52 Week Low
$10.14
Market cap
1.1B
Dividend yield
0.00%
Volume
23,148
Avg. volume
1.5M
P/E ratio
-1.75